Henoch-Schonlein purpura: Polymorphisms in thrombophilia genes

Pediatric Nephrology

Volumn 21, Issue 8, 2006, Pages 1117-1121

  Dagan, Efrat ^a   Brik, Riva ^b   Broza, Yiphtah ^c   Gershoni Baruch, Ruth ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

FVL; Henoch Schonlein purpura; MTHFR; PT Factor II

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; PROTHROMBIN; STEROID;

ADOLESCENT; ANAPHYLACTOID PURPURA; ARAB; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HEMATURIA; HOMOZYGOSITY; HUMAN; HYPERCOAGULABILITY; JEW; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; THROMBOPHILIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; PURPURA, SCHOENLEIN-HENOCH; THROMBOPHILIA;

EID: 33746127606     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0155-x     Document Type: Article

References (26)

1. Kurotobi S, Kawakami N, Honda A, Matsuoka T, Hara T, Nagai T, Shimizu K, Ozono K (2004) Impaired vascular endothelium-depended relaxation in Henoch-Schonlein purpura. Pediar Nephrol 19:138-143
2. Wen YK, Yang Y, Chang CC (2005) Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schonlein purpura treated with plasmapheresis. Pediatr Nephrol 20:223-225
3. Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL (2005) Renal manifestations in Henoch-Schonlein purpura: A 10-year clinical study. Pediatr Nephrol 20:1269-1272
4. Shin JI, Park JM, Lee SM, Shin YH, Kim JH, Lee JS, Kim MJ (2006) Factors affecting histological regression of crescentic Henoch-Schonlein nephritis in children. Pediatr Nephrol 21:54-59
5. Halling SF, Soderberg MP, Berg UB (2005) Henoch-Schonlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol 20:46-51
6. Watanabe T, Oda Y (2000) Henoch-Schonlein purpura nephritis associated with human parvovirus B19 infection. Pediatr Int 42:94-96
7. Veraldi S, Mancuso R, Rizzitelli G, Gianotti R, Ferrante P (1999) Henoch-Schonlein syndrome associated with human Parvovirus B19 primary infection. Eur J Dermatol 9:232-233
8. al-Sheyyab M, el-Shanti H, Ajlouni S, Batieha A, Daoud AS (1996) Henoch-Schonlein purpura: Clinical experience and contemplations on a streptococcal association. J Trop Pediatr 42:200-203
9. Sola Alberich R, Jammoul A, Masana L (1997) Henoch-Schonlein purpura associated with acetylsalicylic acid. Ann Intern Med 126:665
10. Escudero A, Lucas E, Vidal JB, Sanchez-Guerrero I, Martinez A, Illan F, Ramos J (1996) Drug-related Henoch-Schonlein purpura. Allergol Immunopathol 24:22-24
11. Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A (2005) Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura. Rheumtol Int 25:45-48
12. Ha TS (2005) The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol 20:149-153
13. Yang YH, Lai HJ, Kao CK, Lin YT, Chiang BL (2004) The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schonlein purpura. Pediatr Nephrol 19:972-975
14. Boros G, Gofman L, Samsik J, Nagy J, Hamori A, Deak G (1979) Blood coagulation abnormalities in the Schonlein-Henoch syndrome in adults. Acta Med Acad Sci Hung 36:151-166
15. Prandota J, Pankow-Prandota L, Kotecki L (2001) Impaired activation of the fibrinolytic system in children with Henoch-Schonlein purpura: beneficial effect of hydrocortisone plus sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 8:11-19
16. De Mattia D, Penza R, Giordano P, Del Vecchio GC, Aceto G, Altomare M, Schettini F (1995) von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol 9:603-605
17. Dalens B, Bezou MJ, Goumy P, Demeocq F, Menut G (1980) The prognostic value of factor XIII in Schonlein-Henoch purpura in childhood. Arch Fr Pediatr 37:99-101
18. Kaneko K, Fujii S, Shono T, Matsumoto Y, Arii N, Kaneko K (2004) Diagnostic value of plasma factor XIII in Henoch-Schonlein purpura. Pediatr Nephrol 19:702-703
19. Bertina RM (1997) Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 43:1678-1683
20. Zoller B, Svensson PJ, He X, Dahlback B (1994) Identification of the same factor V gene mutation protein C. J Clin Invest 94:2521-2524
21. Bertina RM, van Tilburg NH, de Foue NJ, Haverkate F (1992) Thrombin, a link between coagulation activation and fibrinolysis. Ann NY Acad Sci 667:239
22. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
23. Gurgay A (1999) Clinical manifestation in thrombotic children with factor V Leiden mutation. Pediatr Hematol Oncol 16:233-237
24. Michel BA, Hunder GG, Bloch DA, Calabrese LH (1992) Hypersensitivity vasculitis and Henoch-Schonlein purpura: A comparison between 2 disorders. J Rheumatol 19:721-728
25. Bertina RM, Koelman BPC, Koster T, Rosendaal FR, Driven RJ, de Rondo H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V association with resistance to activated protein C. Nature 369:64-67
26. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703